Literature DB >> 9300532

"PERFEXT": a direct method for quantitative assessment of cytokine production in vivo at the local level.

M Villavedra1, H Carol, M Hjulström, J Holmgren, C Czerkinsky.   

Abstract

A method termed "PERFEXT", based on sequential perfusion and detergent extraction of lymphoid and non-lymphoid organs, has been developed for the quantitative measurement of cytokines produced at a local level in a given tissue. In vivo treatment of mice with Staphylococcus enterotoxin B (SEB) or lipopolysaccharide (LPS) served as the model systems. Interleukin-2 (IL2) and interferon-gamma (IFN gamma) levels were monitored by ELISA analysis of extracted samples. After local footpad (FP) injection with SEB, spleen and serum IL2 levels peaked at 2-4 h, while IL2 levels peaked at around 4-8 h in both FP and popliteal lymph nodes. SEB injection resulted in increased IFN gamma levels both in the FP and the draining lymph node. The detection of cytokines in the intestine allows for the application of the method at mucosal sites as well, provided enzyme inhibitors are present during the extraction procedure. After FP injection with LPS, IFN gamma production was significantly increased in the draining lymph node and was detectable in the FP, whereas IL2 was undetectable in any organ examined. IL2 and IFN gamma could also be detected at the site of elicitation of a delayed-type hypersensitivity reaction following local FP challenge. Local cytokine production correlated with the swelling response, whereas cytokine production in the spleen did not. IL2 peaked early, followed by a late increase in IFN gamma production, corresponding to the maximum swelling. This simple method should prove useful for analysing the production of other cytokines in vivo in distinct anatomical compartments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300532     DOI: 10.1016/s0923-2494(97)80867-x

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  9 in total

1.  CD47-deficient mice have decreased production of intestinal IgA following oral immunization but a maintained capacity to induce oral tolerance.

Authors:  Jessica Westlund; Megan Livingston; Linda Fahlén-Yrlid; Per-Arne Oldenborg; Ulf Yrlid
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

2.  Impairment by mucosal adjuvants and cross-reactivity with variant peptides of the mucosal immunity induced by injection of the fusion peptide PADRE-ELDKWA.

Authors:  Nipa Decroix; Perayot Pamonsinlapatham; Cahn P Quan; Jean-Pierre Bouvet
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

3.  STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia.

Authors:  A B Lentsch; A Kato; B Davis; W Wang; C Chao; M J Edwards
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach.

Authors:  Sukanya Raghavan; Anna Karin Ostberg; Carl-Fredrik Flach; Annelie Ekman; Margareta Blomquist; Cecil Czerkinsky; Jan Holmgren
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

5.  A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.

Authors:  Louise Sjökvist Ottsjö; Carl-Fredrik Flach; John Clements; Jan Holmgren; Sukanya Raghavan
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

6.  Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines.

Authors:  Aqel Albutti; Stephanie Longet; Craig P McEntee; Shauna Quinn; Alex Liddicoat; Cristiana Rîmniceanu; Nils Lycke; Lydia Lynch; Susanna Cardell; Ed C Lavelle
Journal:  Vaccines (Basel)       Date:  2021-06-08

Review 7.  Buccal and sublingual vaccine delivery.

Authors:  Heleen Kraan; Hilde Vrieling; Cecil Czerkinsky; Wim Jiskoot; Gideon Kersten; Jean-Pierre Amorij
Journal:  J Control Release       Date:  2014-06-06       Impact factor: 9.776

8.  An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses.

Authors:  Stephanie Longet; Aine Abautret-Daly; Sukanya Raghavan; Ed C Lavelle; Christopher J H Davitt; Craig P McEntee; Vincenzo Aversa; Monica Rosa; Ivan S Coulter; Jan Holmgren
Journal:  NPJ Vaccines       Date:  2019-10-25       Impact factor: 7.344

9.  Cellular and molecular changes and immune response in the intestinal mucosa during Trichinella spiralis early infection in rats.

Authors:  María Priscila Saracino; Cecilia Celeste Vila; Melina Cohen; María Virginia Gentilini; Guido Hernán Falduto; Marcela Adriana Calcagno; Estela Roux; Stella Maris Venturiello; Emilio Luis Malchiodi
Journal:  Parasit Vectors       Date:  2020-10-06       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.